title: The shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy.
abstract: Respiratory manifestations of systemic lupus erythematosus (SLE) are frequent. The 'shrinking lung syndrome' (SLS) represents a rare complication of SLE. The pathogenesis and therapy of the SLS remains controversial. We report a series of five consecutive cases with the SLS of which we provide a detailed description of the extent and dynamics of the response to corticosteroid therapy.
authors.affiliation: Pulmonology Department, Division of Clinical Immunology & Rheumatology, Academic Medical Centre, Amsterdam, The Netherlands.
authors.forename: K T M
authors.initials: KT
authors.lastname: Oud
authors.forename: P
authors.initials: P
authors.lastname: Bresser
authors.forename: R J M
authors.initials: RJ
authors.lastname: ten Berge
authors.forename: R E
authors.initials: RE
authors.lastname: Jonkers
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy* / Q000209:etiology; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D013577:Syndrome
chemical_list: D000305:Adrenal Cortex Hormones; D011239:Prednisolone; D008775:Methylprednisolone